Apollon Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Apollon Wealth Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$234K	Buy	+969	New	+$212K	﹤0.01%	1413

Other funds holding JAZZ

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

ACM

Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

BCM

BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Apollon Wealth Management's JAZZ Position: Q2 2026 in Review

Apollon Wealth Management opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 969 shares worth $234K. The stake represents ﹤0.01% of the portfolio and ranks #1413 among its holdings.

130 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Apollon Wealth Management held 969 shares of Jazz Pharmaceuticals worth $234K as of Q2 2026.
Jazz Pharmaceuticals was a new Apollon Wealth Management position in Q2 2026.
Jazz Pharmaceuticals made up ﹤0.01% of Apollon Wealth Management's portfolio in Q2 2026, its #1413 holding.
130 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Apollon Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.